Efficacy and Safety of Trastuzumab Rezetecan or Trastuzumab Deruxtecan in Advanced Breast Cancer

NCT07630103 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Advanced Breast Cancer

Interventions

DRUG: Trastuzumab Rezetecan for Injection (SHR-A1811)
DRUG: Trastuzumab Deruxtecan for Injection (T-DXd)

Sponsor

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University